Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

ClinicalTrials.gov ID: NCT01972854

Public ClinicalTrials.gov record NCT01972854. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are to evaluate the safety and efficacy of corneal collagen cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as compared to placebo in impeding the progression of, and/or reducing, maximum corneal curvature.

Study identification

NCT ID
NCT01972854
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Glaukos Corporation
Industry
Enrollment
92 participants

Conditions and interventions

Conditions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2013 (Type not available)
Primary completion
Mar 2016 (Actual)
Completion
Apr 2017 (Actual)
Last update posted
Apr 26, 2021

2013 – 2017

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
UC Irvine Department of Ophthalmology Irvine California 92868 —
Gordon -Weiss Vision Institute San Diego California 92122 —
Price Vision Group Indianapolis Indiana 46260 —
Durrie Vision Overland Park Kansas 66211 —
Ophthalmic Consultants of Boston Waltham Massachusetts 02451 —
Hersh Vision Group Teaneck New Jersey 07666 —
UPMC Eye Center Pittsburgh Pennsylvania 15213 —
Vance Thompson Vision Sioux Falls South Dakota 57105 —
Focal Point Vision San Antonio Texas 78229 —
Hoopes Vision Draper Utah 84020 —
See Clearly Vision McLean Virginia 22102 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01972854, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01972854 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →